References
- AllemaniCWeirHKCarreiraHGlobal surveillance of cancer survival 1995–2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2)Lancet20153859972977101025467588
- TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal Cancer Statistics, 2012CA Cancer J Clin20156528710825651787
- SiegelRMaJZouZJemalACancer Statistics, 2014CA Cancer J Clin201464192924399786
- PhillipsTAHowellAGrieveRJWellingPGPharmacokinetics of oral and intravenous fluorouracil in humansJ Pharm Sci19806912142814317463330
- FraileRJBakerLHBurokerTRHorwitzJVaitkeviciusVKPharmacokinetics of 5-fluorouracil administered orally, by rapid intravenous and by slow infusionCancer Res1980407222322287388790
- LongleyDBHarkinDPJohnstonPG5-Fluorouracil: mechanisms of action and clinical strategiesNat Rev Cancer20033533033812724731
- ParkerWBChengYCMetabolism and mechanism of action of 5-fluorouracilPharmacol Ther19904833813951707544
- GamelinECDanquechinDorvalEMDumesnilYFRelationship between 5-fluorouracil (5-FU) dose intensity and therapeutic response in patients with advanced colorectal cancer receiving infusional therapy containing 5-FUCancer19967734414518630950
- Di PaoloADanesiRFalconeARelationship between 5-fluorouracil disposition, toxicity and dihydropyrimidine dehydrogenase activity in cancer patientsAnn Oncol20011291301130611697844
- KuropkatCGriemKClarkJRodriguezERHutchinsonJTaylorSGSevere cardiotoxicity during 5-fluorouracil chemotherapy – a case and literature reportAm J Clin Oncol199922546647010521060
- AnithaAMayaSSivaramAJMonyUJayakumarRCombinatorial nanomedicines for colon cancer therapyWiley Interdiscip Rev Nanomed Nanobiotechnol20168115115926061225
- JainSKChaurasiyaAGuptaYDevelopment and characterization of 5-FU bearing ferritin appended solid lipid nanoparticles for tumour targetingJ Microencapsul200825528929718608808
- WangLLZhengWSChenSHFangXQDevelopment of in situ gelling and bio adhesive 5-fluorouracil enemaPLoS One201388e7103723976976
- PokornyRMWrightsonWRLewisRKSuppository administration of chemotherapeutic drugs with concomitant radiation for rectal cancerDis Colon Rectum19974012141414209407977
- TakahashiTKohnoKYamaguchiTNarisawaTPreoperative use of 5-fluorouracil suppository for carcinoma of the rectumAm J Surg198214321831857058985
- GalandiukSWrightsonWMarrLMyersSLaRoccaRVSuppository delivery of 5-fluorouracil in rectal cancerAnn Surg Oncol1996332702768726182
- IchikawaDYamaguchiTYoshiokaYJSawaiKTakahashiTPrognostic evaluation of preoperative combined treatment for advanced cancer in the lower rectum with radiation, intraluminal hyperthermia, and 5-fluorouracil suppositoryAm J Surg199617133463508615470
- HorieHKashiwagiHKonishiFFurutaKOzawaAKanazawaKImproved outcome following preoperative radiochemotherapy: 40.5 Gy accelerated hyperfractionation and 5-fluorouracil suppositories for patients with carcinoma of the lower rectumSurg Today1999291099299810554320
- PaekSHXuanJJChoiHGPoloxamer 188 and propylene glycol-based rectal suppository enhances anticancer effect of 5-fluorouracil in miceBiol Pharm Bull20062951060106316651748
- NishiokaBWatanabeSFijitaYClinical studies of intrarectal administration of 5FU emulsion as an adjunct to surgical treatment for rectal cancerJpn J Surg19801021101147431683
- WatanabeSNishiokaBFujitaYExperimental studies of intrarectal administration of emulsified 5FU as an adjuvant to the surgical treatment of rectal cancerJpn J Surg19801021721
- RougierPNordlingerBLarge-scale trial for adjuvant treatment in high-risk resected colorectal cancers – rationale to test the combination of loco-regional and systemic chemotherapy and to compare l-leucovorin plus 5-FU to levamisole plus 5-FUAnn Oncol19934suppl 2S21S28
- AnithaAMayaSChennazhiKPLakshmananVJayakumarRIn vitro combinatorial anticancer effects of 5-fluorouracil and curcumin loaded N, O-carboxymethyl chitosan nanoparticles towards colon cancer and in vivo pharmacokinetic studiesEur J Pharm Biopharm201488123825124815764
- AnithaADeepaNChennazhiKPLakshmananVJayakumarRCombinatorial anticancer effects of curcumin and 5-fluorouracil loaded thiolated chitosan nanoparticles towards colon cancer treatmentBiochim Biophys Acta2014184092730274324946270
- SaeedniaLUstaAAsmatuluRPreparation and Characterization of Drug-loaded Thermosensitive HydrogelsSan Diego, CAASME International Mechanical Engineering Congress and Exposition20131521
- ShishuKamalpreetMaheshwariMDevelopment and evaluation of novel microemulsion based oral formulations of 5-fluorouracil using non-everted rat intestine sac modelDrug Dev Ind Pharm201238329430021864111
- TenjarlaSMicroemulsions: an overview and pharmaceutical applicationsCrit Rev Ther Drug Carrier Syst199916546152110635455
- HaussDJFogalSEFicorilliJVLipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitorJ Pharm Sci19988721641699519148
- ChenHBChangXLDuDRLiJXuHBYangXLMicroemulsion-based hydrogel formulation of ibuprofen for topical deliveryInt J Pharm20063151–2525816600540
- ChoiHGOhYKKimCKIn situ gelling and mucoadhesive liquid suppository containing acetaminophen: enhanced bioavailabilityInt J Pharm199816512332
- KimCKLeeSWChoiHGTrials of in situ gelling and mucoadhesive acetaminophen liquid suppository in human subjectsInt J Pharm19981741–2201207
- ParkYJYongCSKimHMEffect of sodium chloride on the release, absorption and safety of diclofenac sodium delivered by poloxamer gelInt J Pharm20032631–210511112954185
- RyuJMChungSJLeeMHKimCKShimCKIncreased bioavailability of propranolol in rats by retaining thermally gelling liquid suppositories in the rectumJ Control Release199959216317210332051
- KlimaszewskaKBernier-CardouMCyrDRSuttonBCSInfluence of gelling agents on culture medium gel strength, water availability, tissue water potential, and maturation response in embryogenic cultures of Pinus strobus LIn Vitro Cell Dev Biol Plant2000364279286
- KoffiAAAgnelyFPonchelGGrossiordJLModulation of the rheological and mucoadhesive properties of thermosensitive poloxamer-based hydrogels intended for the rectal administration of quinineEur J Pharm Sci200627432833516356700
- KoffiAAAgnelyFBesnardMBrouJKGrossiordJLPonchelGIn vitro and in vivo characteristics of a thermogelling and bioadhesive delivery system intended for rectal administration of quinine in childrenEur J Pharm Biopharm200869116717518023982
- GangulySDashAKA novel in situ gel for sustained drug delivery and targetingInt J Pharm20042761–2839215113617
- MooreTCroySMallapragadaSPanditNExperimental investigation and mathematical modeling of Pluronic (R) F127 gel dissolution: drug release in stirred systemsJ Control Release2000672–319120210825553
- AndersonBCPanditNKMallapragadaSKUnderstanding drug release from poly(ethylene oxide)-b-poly(propylene oxide)-b-poly(ethylene oxide) gelsJ Control Release2001701–215716711166416
- ChenMJChengYMLaiPHWuJFHsuYCIn vitro biocompatibility of thermally gelling liquid mucoadhesive loaded curcuminoids in colorectal cancer chemopreventionInt J Colorectal Dis201227786987822222465
- JeongBKimSWBaeYHThermosensitive sol-gel reversible hydrogelsAdv Drug Deliv Rev2002541375111755705